LESLIE ZELENKO

KOUNTOUPES DENHAM CARR & REID, LLC · Washington, DC · registered since 2024

Registered · LDAActive

Send proposal →Contact →Claim this profile →

At a glance

Registered since

2024

Senate LDA system

Clients

last 3 years

Filings

8 agencies contacted

Activity

filings by quarter

Works on

Health Issues 43 Pharmacy 16 Medicare/Medicaid 14 Consumer Issues/Safety/Products 4 Budget/Appropriations 4 Transportation 3 Science/Technology 3 Labor Issues/Antitrust/Workplace 3 Computer Industry 3 Defense 3 Veterans 2 Manufacturing 1 Insurance 1 Environment/Superfund 1 Civil Rights/Civil Liberties 1

Background

Government experience

Deputy Assistant Secretary for Legislation

Senior Advisor/Congressional Liaison-HHS; Legislative Director,Senior Legislative Assistant,Legislative Assistant,Legislative Correspondent-Cong. Mark Pocan, D-WI; Staff Assistant-Cong. Tam

Disclosed on LD-2 filings

Deputy Assistant Secretary for Legislation

Senior Advisor/Congressional Liaison-HHS; Legislative Director,Senior Legislative Assistant,Legislative Assistant,Legislative Correspondent-Cong. Mark Pocan, D-WI; Staff Assistant-Cong. Tammy Baldwin, D-WI

Disclosed on LD-2 filings

Deputy Assistant Secretary for Legislation

Disclosed on LD-2 filings

Career

KOUNTOUPES DENHAM CARR & REID, LLC

Washington, DC

2024 - present

Specific issues

Issues related to paid leave and retirement savings.

Labor Issues/Antitrust/Workplace · 2024 Q3

Issues related to supplemental health insurance and Family and Medical Leave.

Health Issues · 2024 Q3

General education about federal health research and pandemic preparedness. Issues related to the reauthorization of the Pandemic and All Hazards Preparedness Act (Public Law 109-417), focusing on medical and health research. Issues related to federal research policies including rare and neglected tropical diseases.

Health Issues · 2024 Q3

Issues related to the Fiscal Year 2025 Labor-Health and Human Services Appropriations bills.

Budget/Appropriations · 2024 Q3

Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.

Health Issues · 2024 Q3

Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R.1691, The Ensuring Patient Access to Critical Breakthrough Products Act of 2023. Issues related to appropriate reimbursement for radiopharmaceuticals.

Medicare/Medicaid · 2024 Q3